{
 "as_of": "2026-11-06",
 "cmr": "se-cm-kg/SSME/SE0005162880",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Diamyd Medical AB ser. B (First North Sweden: SE0005162880) — research page\n\nAs of 2026-11-06 · se-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Diamyd Medical AB ser. B, listed on First North Sweden under ticker SE0005162880. Its ISIN is SE0005162880 and its LEI is 5493003NP2HNQDEKB804. Security type, segment, sector and jurisdiction are not on the record. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 74 filings in the twelve months to 2026-11-06, across 37 filing days. The median gap between filing days is 6.5 days, against a median of 11.0 days for First North Sweden, where the record holds 325 issuers. The latest filing is dated 2026-10-29 and is a Notice to general meeting, 8 days before the record date. The exchange median latency is 7 days. Sector medians are not on the record.\n\n## Auditor\n\nThe auditor of record and its location are not on the record. The market's record does not carry auditor changes.\n\n## Events and halts\n\nThe record carries no listing, delisting, name change, domicile change or segment move lines, because this register has no lifecycle type map yet. The issuer is listed and not halted.\n\n## Orderability\n\nThe outcome is not determinable under rule acm-68000/se/mifid-ii-product-governance/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.\n\n## Coverage\n\nThe record names one research house on the issuer's investor-relations page: DNB Carnegie.\n\n## Open research\n\nThe record holds one openly published research note, by Khandaker Partners, dated 2006-07-06.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, and the earliest sealed date and the live record start date are not on the record.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.se-cm-kg.ai/events/SSME/SE0005162880 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)\n- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.diamyd.com/docs/Investors.aspx (coverage)\n- https://www.diamyd.com/docs/pdf/analys/Diamyd_Medical_060706_Final.pdf (open research)\n- https://mcp.se-cm-kg.ai/record/SSME/SE0005162880 (the record)\n",
 "market": "SE",
 "node": "se-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the SE vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "SE",
    "state": "not_on_record"
   },
   "changes": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "se-cm-kg/SSME/SE0005162880",
  "coverage": {
   "count": 1,
   "houses": [
    {
     "analyst": "Maria Karlsson Osipova",
     "house": "DNB Carnegie",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.diamyd.com/docs/Investors.aspx",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.diamyd.com/docs/Investors.aspx",
     "result": "read: 1 of 2 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 325,
     "median_cadence_gap_days": 11,
     "median_filings": 21,
     "median_latency_days": 7,
     "name": "First North Sweden"
    },
    "sector": {
     "market": "SE",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Half year financial report": 2,
    "Inside information": 12,
    "Interim report (Q1 and Q3)": 4,
    "Investor News": 1,
    "Notice to general meeting": 3,
    "Other information disclosed according to the rules of the Exchange": 52
   },
   "cadence_median_gap_days": 6.5,
   "filing_days": 37,
   "filings": 74,
   "latency_days": 8,
   "latest": [
    {
     "category": "Notice to general meeting",
     "date": "2026-10-29",
     "source": "https://view.news.eu.nasdaq.com/view?id=ba5c5ca182d201ecce31dba17fdc368b8&lang=sv&src=listed",
     "title": "Kallelse till årsstämma i Diamyd Medical AB",
     "type": "Notice to general meeting"
    },
    {
     "category": "Other information disclosed according to the rules of the Exchange",
     "date": "2026-10-07",
     "source": "https://view.news.eu.nasdaq.com/view?id=b70d510d53f82e70b222665ad3110d174&lang=en&src=listed",
     "title": "Year-End Report 25/26",
     "type": "Other information disclosed according to the rules of the Exchange"
    },
    {
     "category": "Other information disclosed according to the rules of the Exchange",
     "date": "2026-10-07",
     "source": "https://view.news.eu.nasdaq.com/view?id=b2536f92301810352f56737b9497b34e1&lang=sv&src=listed",
     "title": "Bokslutskommuniké 25/26",
     "type": "Other information disclosed according to the rules of the Exchange"
    },
    {
     "category": "Investor News",
     "date": "2026-09-29",
     "source": "https://view.news.eu.nasdaq.com/view?id=b2865425de5e56b26a2d9a4e142bd3b47&lang=en&src=listed",
     "title": "Now published: Retogatein from Diamyd Medical delays the need for insulin by more than five years in the randomized, placebo-controlled diabetes prevention - Immune Tolerance Trial",
     "type": "Investor News"
    },
    {
     "category": "Other information disclosed according to the rules of the Exchange",
     "date": "2026-07-27",
     "source": "https://view.news.eu.nasdaq.com/view?id=bd5a7b16c8aed38934e0372193cc302ad&lang=sv&src=listed",
     "title": "Diamyd Medical ger en uppdatering om lärdomar från interimsanalysen i DIAGNODE-3",
     "type": "Other information disclosed according to the rules of the Exchange"
    }
   ],
   "latest_filing_date": "2026-10-29",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0005162880",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "First North Sweden"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0005162880"
   },
   "jurisdiction": {
    "market": "SE",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN SE0005162880)",
    "state": "sourced",
    "value": "5493003NP2HNQDEKB804"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Diamyd Medical AB ser. B"
   },
   "sector": {
    "market": "SE",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "SE",
    "state": "not_on_record"
   },
   "segment": {
    "market": "SE",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0005162880"
   },
   "website": {
    "market": "SE",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "SE",
  "node": "se-cm-kg",
  "numbers_hash": "sha256:7b6990fa279e64e1d5878d58919447942fdf117e62fe4cc69cafbff61154a1ed",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2006-07-06",
     "kind": "issuer-sponsored",
     "publisher": "Khandaker Partners",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://www.diamyd.com/docs/pdf/analys/Diamyd_Medical_060706_Final.pdf",
     "state": "sourced",
     "title": "Initiation of Coverage"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://se.eu-cm-kg.ai/book/aio.json",
    "door": "https://se.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/se/mifid-ii-product-governance/r1",
   "section": "se.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.se-cm-kg.ai/record/SSME/SE0005162880",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:7b6990fa279e64e1d5878d58919447942fdf117e62fe4cc69cafbff61154a1ed",
 "path": "/se/SSME/SE0005162880",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Diamyd Medical AB ser. B, listed on First North Sweden under ticker SE0005162880. Its ISIN is SE0005162880 and its LEI is 5493003NP2HNQDEKB804. Security type, segment, sector and jurisdiction are not on the record. The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 74 filings in the twelve months to 2026-11-06, across 37 filing days. The median gap between filing days is 6.5 days, against a median of 11.0 days for First North Sweden, where the record holds 325 issuers. The latest filing is dated 2026-10-29 and is a Notice to general meeting, 8 days before the record date. The exchange median latency is 7 days. Sector medians are not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record and its location are not on the record. The market's record does not carry auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record carries no listing, delisting, name change, domicile change or segment move lines, because this register has no lifecycle type map yet. The issuer is listed and not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable under rule acm-68000/se/mifid-ii-product-governance/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The record names one research house on the issuer's investor-relations page: DNB Carnegie.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds one openly published research note, by Khandaker Partners, dated 2006-07-06.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, and the earliest sealed date and the live record start date are not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0005162880"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation"
  },
  {
   "for": "the orderability chapter",
   "source": "https://se.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.diamyd.com/docs/Investors.aspx"
  },
  {
   "for": "open research",
   "source": "https://www.diamyd.com/docs/pdf/analys/Diamyd_Medical_060706_Final.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.se-cm-kg.ai/record/SSME/SE0005162880"
  }
 ],
 "title": "Diamyd Medical AB ser. B (SE0005162880) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}